INS and type 2 diabetes mellitus: However, some of the current oral antidiabetic drugs like sulfonylureas (SUs) and thiazolidinediones promote weight gain [10], as do insulin formulations, making their use to improve glycemic control somewhat problematic in obese patients with T2DM.